Biocon Limited (NSE: BIOCON), ISIN INE376G01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BIOCON last traded at ₹427.20 (-0.85%), with a 52-week range of ₹331.00 to ₹447.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 44.68%, FIIs 8.14%, DIIs 23.38%, mutual funds 15.47%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.